Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             113 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests Belozertseva, I.V.
 2007
 17 Supplement 2 p. 172-179
8 p.
 artikel
2 Antipsychotic augmentation of serotonergic antidepressants in treatment-resistant obsessive–compulsive disorder: A meta-analysis of the randomized controlled trials Skapinakis, Petros
 2007
 17 Supplement 2 p. 79-93
15 p.
 artikel
3 Association of the serotonin transporter promotor polymorphism with suicide attempters with a high medical damage Wasserman, Danuta
 2007
 17 Supplement 2 p. 230-233
4 p.
 artikel
4 Association study between the dopamine receptor D4 gene and obsessive-compulsive disorder Camarena, Beatriz
 2007
 17 Supplement 2 p. 406-409
4 p.
 artikel
5 C.18.03 Advances in therapeutic treatment of negative and cognitive symptoms of schizophrenia: comprehensive and long-term treatment Carpenter Jr., W.
 2007
 17 Supplement 2 p. S610-
1 p.
 artikel
6 C.12.01 From circadian rhythms to clock genes in depression Turek, F.
 2007
 17 Supplement 2 p. S605-
1 p.
 artikel
7 C.05.02 Molecular mechanisms of the mammalian circadian clock: identifying the clock genes Hastings, M.
 2007
 17 Supplement 2 p. S600-
1 p.
 artikel
8 C.04.02 Treatments for bipolar depression: monotherapy or concomitant therapy Calabrese, J.R.
 2007
 17 Supplement 2 p. S599-
1 p.
 artikel
9 Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects Ritsner, Michael
 2007
 17 Supplement 2 p. 358-365
8 p.
 artikel
10 ECNP Calendar of Events 2007
 17 Supplement 2 p. CO4-
1 p.
 artikel
11 Editorial Board 2007
 17 Supplement 2 p. IFC-
1 p.
 artikel
12 Editorial Board 2007
 17 Supplement 2 p. CO2-
1 p.
 artikel
13 E.01.03 Endophenotypes in addiction Heinz, A.
 2007
 17 Supplement 2 p. S221-S222
2 p.
 artikel
14 Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat Abumaria, Nashat
 2007
 17 Supplement 2 p. 417-429
13 p.
 artikel
15 Effects of the 5-HT1B receptor antagonist NAS-181 on extracellular levels of acetylcholine, glutamate and GABA in the frontal cortex and ventral hippocampus of awake rats: A microdialysis study Hu, Xiao Jing
 2007
 17 Supplement 2 p. 580-586
7 p.
 artikel
16 Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y1 receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression Jiménez-Vasquez, Patricia A.
 2007
 17 Supplement 2 p. 298-308
11 p.
 artikel
17 Escitalopram prevents relapse of obsessive-compulsive disorder Fineberg, Naomi A.
 2007
 17 Supplement 2 p. 430-439
10 p.
 artikel
18 Genetics and personality traits in patients with social anxiety disorder: A case-control study in South Africa Lochner, Christine
 2007
 17 Supplement 2 p. 321-327
7 p.
 artikel
19 P.2.a.010 Association of serotonin transporter polymorphism with depression and norepinephrine in patients with cardiac disease Otte, C.
 2007
 17 Supplement 2 p. S317-
1 p.
 artikel
20 P.4.a.010 Attentional bias for angry, fearful and happy facial expressions in generalized social phobia Garner, M.
 2007
 17 Supplement 2 p. S505-S506
2 p.
 artikel
21 P.2.a.007 Beta-adrenergic receptor responsiveness may predict treatment response in panic disorder Kang, E.H.
 2007
 17 Supplement 2 p. S315-S316
2 p.
 artikel
22 P.4.a.013 Cost of illness of generalized anxiety disorder: a perspective from the primary health-care setting (The ANCORA study) Rovira, J.
 2007
 17 Supplement 2 p. S507-S508
2 p.
 artikel
23 P.3.008 Acute psychotic agitation: is treatment with benzodiazepines enough? Berg, J.E.
 2007
 17 Supplement 2 p. S163-
1 p.
 artikel
24 P.1.a.007 Decision-making behaviour is influenced by tryptophan hydroxylase 2 gene Juhasz, G.
 2007
 17 Supplement 2 p. S231-
1 p.
 artikel
25 P.1.41 β2-adrenoceptor activation induces expression of IL-1ra and the IL-1R(II) in vivo: implications for CNS inflammation Mc Namee, E.N.
 2007
 17 Supplement 2 p. S35-S36
2 p.
 artikel
26 P.8.a.008 Effect of comorbidities and adverse events on clinical global impressions ratings Busner, J.
 2007
 17 Supplement 2 p. S584-
1 p.
 artikel
27 P.7.a.003 Efficacy of aripiprazole in the treatment of adolescents with schizophrenia Nyilas, M.
 2007
 17 Supplement 2 p. S568-
1 p.
 artikel
28 P.1.a.016 Epigenetic dysregulation of DAT and DRD2 but not DRD1 and DRD4 mRNA expression in females with eating disorders Frieling, H.
 2007
 17 Supplement 2 p. S236-S237
2 p.
 artikel
29 P.1.a.002 Expression of hippocampal NR1 subunit of NMDA receptor in heuristic and genetic model of schizophrenia Stastny, F.
 2007
 17 Supplement 2 p. S227-S228
2 p.
 artikel
30 P.5.a.007 How to manage suicidal behaviour in elderly Vucko Miklavcic, I.
 2007
 17 Supplement 2 p. S529-S530
2 p.
 artikel
31 P.5.a.010 Impact of CYP3A4 polymorphisms on donepezil plasma levels and therapeutic outcome Scordo, M.G.
 2007
 17 Supplement 2 p. S531-S532
2 p.
 artikel
32 P.8.a.005 Plasma amino acids and neopterin in healthy subjects with Down's syndrome Verhoeven, W.M.A
 2007
 17 Supplement 2 p. S582-S583
2 p.
 artikel
33 P.3.a.015 Relation between working memory and negative symptoms and other factors in patients with first episode of schizophrenia Libera, U.
 2007
 17 Supplement 2 p. S409-S410
2 p.
 artikel
34 P.2.a.024 Social support in anxious and depressive outpatients Vidal Millares, M.
 2007
 17 Supplement 2 p. S325-S326
2 p.
 artikel
35 P.2.20 Assessing the genetic influence on anxiety behaviour and stress-induced brain activation in the mouse O'Mahony, C.M.
 2007
 17 Supplement 2 p. S55-
1 p.
 artikel
36 P.2.a.017 Symptomatic and functional remission of depression in a large observational study (OREON 2) Mignon, A.
 2007
 17 Supplement 2 p. S321-S322
2 p.
 artikel
37 P.6.a.003 The factors affecting codependence and relationship with how to cope with patient in the family of alcoholics Lee, K.S.
 2007
 17 Supplement 2 p. S539-S540
2 p.
 artikel
38 P.8.a.022 Weight-related measures of quality of life in general population and psychiatric patients Yoon, B.
 2007
 17 Supplement 2 p. S592-
1 p.
 artikel
39 P.4.b.005 Attenuation of panic-related behaviors after cholecystokinin type 2 receptor antagonism in the rat periaqueductal gray Bertoglio, L.J.
 2007
 17 Supplement 2 p. S512-S513
2 p.
 artikel
40 P.4.b.011 Decrease in serotonin-1A receptor binding correlates with reduced anxiety scores after 12-week SSRI treatment Spindelegger, C.
 2007
 17 Supplement 2 p. S515-S516
2 p.
 artikel
41 P.2.b.005 Polymorphisms in cytosolic phospholipase A2 and cyclooxygenase 2 genes and risk of interferon-induced depression Su, K.P.
 2007
 17 Supplement 2 p. S334-S335
2 p.
 artikel
42 P.3.b.001 Restoration of latent inhibition in ovariectomized rats by neuroleptics requires estrogen Arad, M.
 2007
 17 Supplement 2 p. S417-S418
2 p.
 artikel
43 P.3.b.004 Subchronic elevation of endogenous levels of kynurenic acid increase dopamine release in rat nucleus accumbens Nilsson-Todd, L.K.
 2007
 17 Supplement 2 p. S419-S420
2 p.
 artikel
44 P.2.b.006 The influence of L-tryptophan on anxiety behavior in young and old rats with imbalance of thyroid hormones Masalova, O.
 2007
 17 Supplement 2 p. S335-
1 p.
 artikel
45 P.3.c.021 Abnormal laboratory findings in emergently injected psychiatric inpatients: a preliminary report Bahk, W.M.
 2007
 17 Supplement 2 p. S436-
1 p.
 artikel
46 P.3.c.007 A naturalistic evaluation of risperidone long-acting injection on nine patients in a high secure hospital Van Hoecke, E.
 2007
 17 Supplement 2 p. S427-S428
2 p.
 artikel
47 P.2.c.015 Better sexual acceptability of agomelatine compared to paroxetine in healthy male volunteers using the PRSexDQ Scale Montejo, A.L.
 2007
 17 Supplement 2 p. S349-
1 p.
 artikel
48 P.1.c.053 Comparative study of the effects of tacrine, donepezil and rivastigmine in rats with diazepam-induced amnesia Dimitrova, D.
 2007
 17 Supplement 2 p. S272-S273
2 p.
 artikel
49 P.3.c.024 Differences of plasma BDNF, β-NGF, and IGF-1 between responder and non-responder in schizophrenic patients Lee, B.H.
 2007
 17 Supplement 2 p. S437-S438
2 p.
 artikel
50 P.2.c.018 Does pindolol reduce latency of action of SSRI administered intravenously? Oller, S.
 2007
 17 Supplement 2 p. S350-S351
2 p.
 artikel
51 P.3.c.055 Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients Kim, H.
 2007
 17 Supplement 2 p. S456-
1 p.
 artikel
52 P.3.c.038 Effects of high doses of amisulpride in psychotic patients not responding to conventional antipsychotics Castaño Asins, J.
 2007
 17 Supplement 2 p. S446-S447
2 p.
 artikel
53 P.1.008 Chronobiological markers and the stability of the circadian rhythm of mood and vigor in psychiatric patients with schizophrenia, affective disorders, and neurotic disorders Madjirova, N.
 2007
 17 Supplement 2 p. S152-S153
2 p.
 artikel
54 P.2.c.005 Impact of tianeptine on cognitive functions in depressed patients Klasik, A.
 2007
 17 Supplement 2 p. S343-S344
2 p.
 artikel
55 P.1.c.039 Increased midbrain dopaminergic firing by the competitive N-methyl-D-aspartate receptor antagonist SDZ 220–581 Olsson, S.K.
 2007
 17 Supplement 2 p. S264-S265
2 p.
 artikel
56 P.1.c.005 Influence of inhibitory neurotransmitters on glutamate release and chloride content in rat brain synaptosomes Fedorovich, S.
 2007
 17 Supplement 2 p. S244-S245
2 p.
 artikel
57 P.3.c.052 Long-term efficacy and safety of bifeprunox in stable patients with schizophrenia: findings from a 6-month study Bourin, M.
 2007
 17 Supplement 2 p. S454-
1 p.
 artikel
58 P.2.c.032 Meta analysis of randomised controlled trials of venlafaxine in the treatment of major depressive disorder Freemantle, N.
 2007
 17 Supplement 2 p. S359-
1 p.
 artikel
59 P.3.c.079 Negative impact of total antipsychotic dosage on cognition as assessed by the Brief Assessment of Cognition in Schizophrenia (BACS) Elie, D.
 2007
 17 Supplement 2 p. S470-
1 p.
 artikel
60 P.1.c.022 PET-measured D2, 5-HT2, and norepinephrine transporter (NET) occupancy by quetiapine and N-desalkyl-quetiapine in non-human primates Nyberg, S.
 2007
 17 Supplement 2 p. S254-S255
2 p.
 artikel
61 P.3.c.065 Quality of life and self-feeling in schizophrenia Kafel, J.
 2007
 17 Supplement 2 p. S462-
1 p.
 artikel
62 P.6.c.002 Striatal dopamine release during a motorbike riding game in ex-chronic ‘ecstasy’ users using [123I] IBZM in SPECT Weinstein, A.
 2007
 17 Supplement 2 p. S550-
1 p.
 artikel
63 P.1.c.008 Various ethanol doses combined with morphine 30 mg do not affect pharmacodyanmic and pharmacokinetic measures Setnik, B.
 2007
 17 Supplement 2 p. S246-S247
2 p.
 artikel
64 P.2.d.009 Changes in glutamatergic transmission in rat frontal cortex induced by chronic imipramine treatment Bobula, B.
 2007
 17 Supplement 2 p. S367-
1 p.
 artikel
65 P.3.d.012 Effects of sertindole and risperidone on extracellular dopamine, acetylcholine and glutamate in the rat frontal cortex Mørk, A.
 2007
 17 Supplement 2 p. S480-
1 p.
 artikel
66 P.2.d.026 Functional interactions between serotonin, norepinephrine and dopamine neurons: an electrophysiological study Guiard, B.P.
 2007
 17 Supplement 2 p. S376-
1 p.
 artikel
67 P.7.d.002 Longitudinal study of neurotrophic factors in children and adolescents with a first psychotic episode Del Moral, E.
 2007
 17 Supplement 2 p. S576-S577
2 p.
 artikel
68 P.1.d.003 Stress-induced c-fos expression in adolescent 6-hydroxydopamine lesioned rats Chung, Y.C.
 2007
 17 Supplement 2 p. S274-S275
2 p.
 artikel
69 P.2.d.012 Vagus nerve stimulation: effects on noradrenergic neuronal firing and serotonin transmission in the rat brain Manta, S.
 2007
 17 Supplement 2 p. S368-S369
2 p.
 artikel
70 P.2.e.014 A multinational assessment of quality of life and resource use by bipolar disorder patients in Europe and the US Leeuwenkamp, O.
 2007
 17 Supplement 2 p. S384-
1 p.
 artikel
71 P.2.e.017 Bipolar disorder treatment guidelines followed by Spanish psychiatrists. GAMEB Study Vieta, E.
 2007
 17 Supplement 2 p. S385-S386
2 p.
 artikel
72 P.6.e.004 CSF amino acids in pathological gamblers and healthy controls Nordin, C.
 2007
 17 Supplement 2 p. S560-
1 p.
 artikel
73 P.2.03 Ecstasy and ethanol interaction effects on psychomotor function Dumont, G.
 2007
 17 Supplement 2 p. S42-
1 p.
 artikel
74 P.3.e.006 Incidence of psychotic relapses and compliance in schizophrenic outpatients and patients in extramural institution Bornivelli, C.
 2007
 17 Supplement 2 p. S490-
1 p.
 artikel
75 P.6.e.001 Oxcarbazepine in treatment of alcohol and heroin craving Zivkovic, N.
 2007
 17 Supplement 2 p. S558-
1 p.
 artikel
76 P.3.e.003 Predictors of abnormal involuntary movement in an African schizophrenia population Niehaus, D.J.H
 2007
 17 Supplement 2 p. S488-
1 p.
 artikel
77 P.1.e.014 Subjective effects of acute dose of hydrocortisone in healthy volunteers Tyacke, R.J.
 2007
 17 Supplement 2 p. S288-S289
2 p.
 artikel
78 P.4.e.003 The further development of a new model of GAD: I – the effects of single dose alprazolam and zolpidem Papadopoulos, A.
 2007
 17 Supplement 2 p. S521-S522
2 p.
 artikel
79 P.1.e.004 The neural substrates of affective face recognition in patients with Hwa-Byung and healthy individuals in Korea Ham, B.J.
 2007
 17 Supplement 2 p. S282-S283
2 p.
 artikel
80 P.2.06 Evidence for a role for neurotrophins in both acquisition and consolidation of recognition memory Callaghan, C.
 2007
 17 Supplement 2 p. S44-S45
2 p.
 artikel
81 P.3.f.002 Effect of the selective glycine re-uptake (GlyT-1) inhibitor Org 25935 on glycine levels in CSF and dialysates Andrews, N.
 2007
 17 Supplement 2 p. S497-S498
2 p.
 artikel
82 P.1.f.002 Link between social cognition and kraepelinian schizophrenia: impact on the functional outcome Bralet, M.C.
 2007
 17 Supplement 2 p. S297-
1 p.
 artikel
83 P.1.f.005 Temperament and character of suicide attempters compared to healthy subjects Calati, R.
 2007
 17 Supplement 2 p. S298-S299
2 p.
 artikel
84 P.2.g.006 Effectiveness of a combination of Hypericum and Passiflora for the treatment of depression with concomitant anxiety Chaudhry, H.R.
 2007
 17 Supplement 2 p. S394-
1 p.
 artikel
85 P.1.g.009 Taurine in plasma and CSF – a study in healthy male volunteers Nordin, C.
 2007
 17 Supplement 2 p. S307-S308
2 p.
 artikel
86 P.3.01 High weight affects treatment response in major depression Kloiber, S.
 2007
 17 Supplement 2 p. S70-S71
2 p.
 artikel
87 P.2.34 H3-receptor antagonists/inverse agonists reverse apomorphine-but not MK-801-induced deficits of prepulse inhibition Burban, A.
 2007
 17 Supplement 2 p. S66-S67
2 p.
 artikel
88 P.2.002 Improvement of resistant depression by combining antidepressive medication with lamotrigine Baloescu, A.
 2007
 17 Supplement 2 p. S154-S155
2 p.
 artikel
89 P.1.19 Regulation of post synaptic calcium influx in hippocampal CA1 pyramidal neurons via extracellular carbonic anhydrase Fedirko, N.
 2007
 17 Supplement 2 p. S17-S18
2 p.
 artikel
90 P.3.15 Repeated electrostimulation of reward-related brain regions alters cocaine but not ‘natural’ reward associated behaviors Levy, D.
 2007
 17 Supplement 2 p. S81-S82
2 p.
 artikel
91 P.4.01 Risperidone in adolescent schizophrenia: a retrospective study Dudová, I.
 2007
 17 Supplement 2 p. S91-S92
2 p.
 artikel
92 P.1.33 Role of endocannabinoids in the modulation of anxious states in rat prefrontal cortex Realini, N.
 2007
 17 Supplement 2 p. S29-S30
2 p.
 artikel
93 P.1.16 Social isolation alters GABAA receptors plasticity and function: effect of ethanol Pisu, M.G.
 2007
 17 Supplement 2 p. S15-
1 p.
 artikel
94 Psychological and cytokine changes in children and adolescents undergoing hematopoietic stem cell transplantation Munitz-Shenkar, Dafna
 2007
 17 Supplement 2 p. 58-63
6 p.
 artikel
95 Reduced platelet vesicular monoamine transporter density in Tourette's syndrome pediatric male patients Ben-Dor, David H.
 2007
 17 Supplement 2 p. 523-526
4 p.
 artikel
96 Role of acetaldehyde in tobacco smoke addiction Talhout, Reinskje
 2007
 17 Supplement 2 p. 627-636
10 p.
 artikel
97 S.18.02 Cannabis effects on brain function and structure of adolescents and young adults Block, R.I.
 2007
 17 Supplement 2 p. S202-S203
2 p.
 artikel
98 S.25.01 Craving, cue-reactivity, attentional bias and relapse in addiction Franken, I.
 2007
 17 Supplement 2 p. S214-
1 p.
 artikel
99 S.01.01 Developmental psychopathology of aggression Côté, M.
 2007
 17 Supplement 2 p. S175-
1 p.
 artikel
100 S.03.02 Genetic association between 5-HT2C receptor polymorphism (Cys23Ser) and affective disorders in females: a case control study Milanova, V.K.
 2007
 17 Supplement 2 p. S139-S140
2 p.
 artikel
101 S.07.03 I.V. citalopram vs I.V. clomipramine in partial/non-responder depressed patients: a randomized, single-blind study Zanoni, S.
 2007
 17 Supplement 2 p. S186-
1 p.
 artikel
102 S.28.05 Manipulation of brain kynurenic acid levels: a possible treatment for psychiatric symptoms? Kajii, Y.
 2007
 17 Supplement 2 p. S219-
1 p.
 artikel
103 S.08.05 Metabolic parameters of the NO pathway in relationship to psychiatric disorders Akyol, O.
 2007
 17 Supplement 2 p. S190-
1 p.
 artikel
104 S.09.04 Novel options for bipolar illness beyond treatment guidelines Amann, B.
 2007
 17 Supplement 2 p. S191-
1 p.
 artikel
105 S.14.03 Outcome of switching dose or type of atypical antipsychotics Haro, J.M.
 2007
 17 Supplement 2 p. S196-
1 p.
 artikel
106 S.01.04 Psychopharmacological treatment of autism and its comorbid disorders Croonenberghs, J.
 2007
 17 Supplement 2 p. S176-
1 p.
 artikel
107 S.04.04 Social isolation alters GABAA receptors plasticity and function: effect of ethanol Pisu, M.G.
 2007
 17 Supplement 2 p. S181-
1 p.
 artikel
108 State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients Ritsner, Michael
 2007
 17 Supplement 2 p. 257-264
8 p.
 artikel
109 S.01.02 Tension-type headache Milanov, I.
 2007
 17 Supplement 2 p. S133-
1 p.
 artikel
110 S.21.04 Treatment-resistant obsessive-compulsive disorder Pallanti, S.
 2007
 17 Supplement 2 p. S209-
1 p.
 artikel
111 S.21.01 Treatment-resistant panic anxiety disorder Bandelow, B.
 2007
 17 Supplement 2 p. S207-S208
2 p.
 artikel
112 Striatal D2 receptor occupancy in bipolar patients treated with olanzapine Attarbaschi, Trawat
 2007
 17 Supplement 2 p. 102-107
6 p.
 artikel
113 The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion Schneider, Miriam
 2007
 17 Supplement 2 p. 180-186
7 p.
 artikel
                             113 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland